Amgen Inc. buy phonebroker
Start price
29.04.21
/
40%
€196.62
Target price
29.04.22
€217.00
Performance (%)
-3.11%
End price
23.08.21
€190.50
Summary
This prediction ended on 23.08.21 with a price of €190.50. With a performance of -3.11%, the BUY prediction by phonebroker finished with a loss. A total of €2.95 was paid as dividends for this prediction. phonebroker has 40% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | -2.419% | -2.419% | 19.412% | 30.387% |
| iShares Core DAX® | 0.789% | 1.975% | 13.390% | 49.835% |
| iShares Nasdaq 100 | 4.226% | 4.344% | 39.717% | 89.762% |
| iShares Nikkei 225® | 3.285% | 6.991% | 49.894% | 64.380% |
| iShares S&P 500 | 2.496% | 2.759% | 30.229% | 64.245% |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
Buy Amgen Inc.
Kursziel gesetzt auf 217,0